Skip to main content
All lobbying filings

Arnold & Porter Kaye Scholer LLP

Arnold & Porter Kaye Scholer LLP filed a Q2 report for Urac, Inc. on July 17, 2026, reporting $70,000 in lobbying income.

Lobbying for Urac, Inc. · Non-profit accreditation entity for healthcare organizations.

As filed: ARNOLD & PORTER KAYE SCHOLER LLP for URAC, INC.

All filings by Arnold & Porter Kaye Scholer LLP · Everything Urac, Inc. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 17, 2026
Income
$70,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 4

Issues related to health care accreditation, Medicare Advantage plans (including Medicare Advantage Special Needs Plans (SNP) reviews), telehealth, and mental health parity. Issues related to pharmacy benefit management services and specialty pharmacies, including accreditations of both, and the Pharmacists Fight Back in Medicare and Medicaid Act (H.R. 6609). Issues related to health care artificial intelligence accreditation, including report language included in House Report 119-696 [which accompanies the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260)].

Issues related to health care accreditation, mental health parity, and Medicare Advantage plans. Issues related to reforms to the Organ Procurement and Transplantation Network (OPTN), including the role of accreditation. Issues related to pharmacy benefit management services and specialty pharmacies, including accreditations of both, and the Pharmacists Fight Back in Medicare and Medicaid Act (H.R. 6609) and the Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] (H.R. 6610). Issues related to telehealth accreditation, including implementation of report language included in House Report 119-271 [which accompanies the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304)]. Issues related to health care artificial intelligence accreditation, including report language included in House Report 119-696 [which accompanies the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260)].

Issues related to telehealth accreditation, including implementation of report language included in House Report 119-271 [which accompanies the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026 (H.R. 5304)]. Issues related to health care artificial intelligence accreditation, including report language included in House Report 119-696 [which accompanies the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 (H.R. 9260)].

Issues related to accreditation for mental health parity, as well as compliance with federal mental health parity laws and regulations, including the Mental Health Parity and Addiction Equity Act (MHPAEA - Public Law No: 110-343).

 Bills named in this filing 4
  • H.R. 6609
    Pharmacists Fight Back in Medicare and Medicaid Act
  • H.R. 9260
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
  • H.R. 6610
    Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]
  • H.R. 5304
    Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem